Pelthos Therapeutics (PTHS) Return on Equity (2024 - 2025)
Pelthos Therapeutics has reported Return on Equity over the past 2 years, most recently at 0.89% for Q4 2025.
- Quarterly results put Return on Equity at 0.89% for Q4 2025, down 473.0% from a year ago — trailing twelve months through Dec 2025 was 0.89% (down 473.0% YoY), and the annual figure for FY2025 was 2.4%, changed.
- Return on Equity for Q4 2025 was 0.89% at Pelthos Therapeutics, up from 0.91% in the prior quarter.
- Over the last five years, Return on Equity for PTHS hit a ceiling of 3.84% in Q4 2024 and a floor of 0.91% in Q3 2025.